|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-6-7
|
|
pubmed:abstractText |
Heart failure secondary to myocardial iron loading remains the leading cause of death in thalassemia major (TM). We used cardiovascular magnetic resonance (CMR) to assess the prevalence of myocardial iron overload and ventricular dysfunction in a large cohort of TM patients maintained on conventional chelation treatment with deferoxamine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1097-6647
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
543-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16755844-Cardiomyopathies,
pubmed-meshheading:16755844-Chi-Square Distribution,
pubmed-meshheading:16755844-Deferoxamine,
pubmed-meshheading:16755844-Female,
pubmed-meshheading:16755844-Ferritins,
pubmed-meshheading:16755844-Humans,
pubmed-meshheading:16755844-Iron Overload,
pubmed-meshheading:16755844-Italy,
pubmed-meshheading:16755844-Magnetic Resonance Imaging,
pubmed-meshheading:16755844-Male,
pubmed-meshheading:16755844-Myocardium,
pubmed-meshheading:16755844-Natriuretic Peptide, Brain,
pubmed-meshheading:16755844-Prevalence,
pubmed-meshheading:16755844-Siderophores,
pubmed-meshheading:16755844-Ventricular Dysfunction, Left,
pubmed-meshheading:16755844-beta-Thalassemia
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.
|
|
pubmed:affiliation |
Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
